Streetbeat News

Earnings

AEHR

Aehr Test Systems reported preliminary Q3 and FY24 adjusted EPS and revenue results that fell below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:38 pm

LUCY

Innovative Eyewear Inc. (NASDAQ: LUCY) reported a 75% increase in FY23 revenue, reaching $1,152,479 from $659,788 YoY. Q4 2023 sales hit a record $615,754, marking the fourth consecutive quarter of growth. Despite this, the net loss widened to $6,663,428 from $5,681,833 due to operational scale-up. The company attributes growth to direct-to-consumer and Amazon sales, and anticipates further growth with the launch of new smart eyewear lines in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:36 pm

LITB

LightInTheBox Holding Co., Ltd. (NYSE:LITB) reported a 13.3% decline in Q4 FY23 sales year-on-year, with a decrease in product sales and a slight increase in services and others sales. The company's gross margin expanded, but gross profit fell. Operating expenses decreased, and the operating loss remained flat. Adjusted EBITDA improved slightly, and loss per ADS decreased significantly. LITB also disclosed receiving an NYSE non-compliance letter and provided a Q1 2024 revenue outlook of $70 million to $80 million. Shares closed higher by 4.94% at $0.7929.

Portfolio Pulse from Shivani Kumaresan

March 25, 2024 | 12:28 pm

ZVSA

ZyVersa Therapeutics reported a Fiscal Year 2023 Earnings Per Share (EPS) of $(108.97), indicating a significant loss.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:26 pm

CMG

CNM

MU

NVDA

SHAK

Wall Street's most accurate analysts have made new stock picks, highlighting potential upsides and downsides in companies like Micron Technology, NVIDIA, Shake Shack, Core & Main, and Chipotle Mexican Grill. These picks are based on recent company performances and market trends, with analysts from firms like Oppenheimer, Truist Securities, Wedbush, Deutsche Bank, and Wells Fargo providing insights.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:23 pm

ARTL

Artelo Biosciences reported its FY23 financial results, showing an EPS of $(3.14) compared to $(3.56) YoY. The company's cash and investments stood at $10.4 million, with R&D expenses at $5.7 million and G&A expenses at $4.2 million. The net loss for the year was $9.3 million, an improvement from the previous year's $10.1 million.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:20 pm

IONS

Ionis Pharmaceuticals announced it will present Phase 3 data for Olezarsen in treating Familial Chylomicronemia Syndrome at the 2024 American College of Cardiology Annual Meeting. The data shows significant reduction in triglycerides and a substantial reduction in acute pancreatitis events in patients with this rare, life-threatening disease, which currently has no approved treatment options in the U.S.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:20 pm

ASTL

Algoma Steel Group Inc. (NASDAQ:ASTL) provided fiscal Q4 2024 guidance, expecting steel shipments between 445,000-460,000 tons and Adjusted EBITDA of C$30M-C$40M. An unplanned outage at its blast furnace significantly impacted the quarter's performance. CEO Michael Garcia highlighted the recovery from the January incident, strong demand, rising market prices for Hot Rolled Coil, and the on-schedule Electric Arc Furnace project as key factors for future improvement.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:19 pm

MTNB

Matinas BioPharma announced results from an additional in vivo study in healthy mice with an oral LNC formulation of Docetaxel, a chemotherapeutic agent. This study is significant for the management of multiple metastatic and unresectable tumors.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:16 pm

OLK

Olink Holding (NASDAQ:OLK) reported Q4 earnings per share (EPS) of $(0.06), missing the analyst consensus estimate of $0.15 by 140%. Quarterly sales were $68.55M, missing the estimate of $89.86M by 23.71%. This represents a 220% decrease in EPS and an 18.43% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:14 pm